Swerdlow AJ et al., 2011-11-01: British cohort of 5,798 Hodgkin lymphoma patients treated with chemotherapy 1963-2001. Chemotherapy alone roughly doubled second-cancer risk, versus nearly fourfold after combined chemotherapy and radiotherapy.
Relative risk (RR) of second cancer was raised after chemotherapy alone (RR, 2.0; 95% CI, 1.7 to 2.4) but was much lower than after combined modalities (RR, 3.9; 95% CI, 3.5 to 4.4).
Abstract (Results)
Swerdlow AJ et al., 2011-11-01: British cohort of 5,798 Hodgkin lymphoma patients treated with chemotherapy 1963-2001. Chemotherapy alone roughly doubled second-cancer risk, versus nearly fourfold after combined chemotherapy and radiotherapy. Comparator: chemotherapy alone vs combined modality vs general population. The paper's own conclusion is that after chemotherapy alone the excess is 'slight if at all after 15 years follow-up', which cuts against reading 15-year risk as a large cumulative percentage. Funder/COI not in the abstract. Useful for the C2 attribution question: chemotherapy alone carries a lower and narrower second-cancer risk than combined-modality treatment.
